Padillo, Michelle .

HRN: 14-27-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2026
CEFUROXIME 500MG (TAB)
07/06/2026
07/13/2026
PO
500mg
BID
S/P Repeat PLTCS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines